Novo Holdings A/S — 13F Holdings

2026 Q3  ·  28 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Novo Holdings A/S maintained a portfolio of 28 distinct positions. The most significant new addition was OBSIDIAN THERAPEUTICS INC, now representing 2.88% of the total fund value. They heavily accumulated shares in BROOKFIELD CORP, increasing the position by 27.7%. The fund also reduced its exposure to MAPLIGHT THERAPEUTICS INC by 43.4%.
Position History hover any row below to update
Loading…
Novo Holdings A/S Hellerup, Denmark Investment Holding Company AUM $1,490M
PCA Score Concentration Risk
Risk ENB
Total Positions
28
Quarter
2026 Q3
Top Holding
EWTX (14.6%)
Top 10 Concentration
73.7%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-28 of 28

Novo Holdings A/S Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
EWTX
EDGEWISE THERAP...
Healthcare 14.58% 12.62% #1
Prev: #1
7.0
—
no change no change
P
S
5,350,000 $217,210,000 2021 Q1 13F Filing 2026-09-30 2026-11-16
ASML
ASML HOLDING N ...
Technology 11.55% 10.97% #2
Prev: #2
6.5
—
no change no change
P
S
94,946 $172,010,820 2022 Q1 13F Filing 2026-09-30 2026-11-16
BN
BROOKFIELD CORP
Financial Services 10.93% 8.68% #3 1
Prev: #4
7.5
—
968,790 27.7%
P
S
4,465,035 $162,795,176 2023 Q3 13F Filing 2026-09-30 2026-11-16
COAG
HEMAB THERAPEUT...
Healthcare 8.65% 8.92% #4 1
Prev: #3
5.0
—
no change no change
P
S
4,180,550 $128,928,162 2026 Q2 13F Filing 2026-09-30 2026-11-16
AVLN
AVALYN PHARMACE...
Healthcare 6.60% 7.42% #5 2
Prev: #7
3.6
—
-434,098 -11.2%
P
S
3,449,191 $98,267,452 2026 Q2 13F Filing 2026-09-30 2026-11-16
MIRM
MIRUM PHARMACEU...
Healthcare 6.46% 7.65% #6
Prev: #6
3.6
—
no change no change
P
S
1,125,000 $96,165,000 2019 Q3 13F Filing 2026-09-30 2026-11-16
CRM
SALESFORCE INC
Technology 6.06% 3.58% #7 1
Prev: #8
3.4
—
no change no change
P
S
393,187 $90,263,940 2022 Q1 13F Filing 2026-09-30 2026-11-16
ELVN
ENLIVEN THERAPE...
Healthcare 3.08% 2.95% #8 2
Prev: #10
2.2
—
no change no change
P
S
1,000,000 $45,840,000 2025 Q2 13F Filing 2026-09-30 2026-11-16
FDMT
4D MOLECULAR TH...
Healthcare 2.88% 2.51% #9 6
Prev: #15
1.7
—
-249,178 -7.7%
P
S
3,000,000 $42,930,000 2023 Q1 13F Filing 2026-09-30 2026-11-16
OBX
OBSIDIAN THERAP...
Healthcare 2.88% — #10
Prev: #—
4.7
—
3,123,992 —
NEW
3,123,992 $42,892,410 2026 Q3 13F Filing 2026-09-30 2026-11-16
PCVX
VAXCYTE INC
Healthcare 2.71% 2.70% #11 3
Prev: #14
1.6
—
-90,000 -11.2%
P
S
710,000 $40,399,000 2020 Q2 13F Filing 2026-09-30 2026-11-16
FND
FLOOR & DECOR H...
Consumer Cyclical 2.45% 2.75% #12 1
Prev: #13
2.0
—
no change no change
P
S
797,000 $36,510,570 2026 Q2 13F Filing 2026-09-30 2026-11-16
VRDN
VIRIDIAN THERAP...
Healthcare 2.42% 2.28% #13 3
Prev: #16
1.5
—
-385,000 -18.0%
P
S
1,750,000 $36,032,500 2024 Q1 13F Filing 2026-09-30 2026-11-16
AVBP
ARRIVENT BIOPHA...
Healthcare 2.39% 3.03% #14 5
Prev: #9
1.0
—
-325,000 -21.7%
P
S
1,175,000 $35,579,000 2024 Q1 13F Filing 2026-09-30 2026-11-16
INSM
INSMED INC
Healthcare 2.18% 0.75% #15 8
Prev: #23
3.9
—
163,702 135.6%
P
S
284,425 $32,464,270 2020 Q2 13F Filing 2026-09-30 2026-11-16
PHVS
PHARVARIS N V
Healthcare 2.17% 2.81% #16 4
Prev: #12
0.9
—
-380,574 -27.2%
P
S
1,019,426 $32,336,193 2021 Q1 13F Filing 2026-09-30 2026-11-16
CLDX
CELLDEX THERAPE...
Healthcare 2.07% 2.21% #17
Prev: #17
1.3
—
-75,000 -7.3%
P
S
950,000 $30,789,500 2024 Q2 13F Filing 2026-09-30 2026-11-16
BABA
ALIBABA GROUP H...
Consumer Cyclical 1.86% 1.43% #18 2
Prev: #20
1.7
—
no change no change
P
S
257,327 $27,672,946 2021 Q1 13F Filing 2026-09-30 2026-11-16
XENE
XENON PHARMACEU...
Healthcare 1.63% 1.70% #19
Prev: #19
3.2
—
166,667 34.3%
P
S
652,105 $24,251,785 2014 Q4 13F Filing 2026-09-30 2026-11-16
SRRK
SCHOLAR ROCK HL...
Healthcare 1.49% — #20
Prev: #—
4.1
—
460,002 —
NEW
460,002 $22,227,297 2026 Q3 13F Filing 2026-09-30 2026-11-16
DYN
DYNE THERAPEUTI...
Healthcare 1.49% 1.24% #21
Prev: #21
3.1
—
415,770 43.3%
P
S
1,376,164 $22,170,002 2026 Q2 13F Filing 2026-09-30 2026-11-16
MPLT
MAPLIGHT THERAP...
Healthcare 1.43% 7.67% #22 17
Prev: #5
0.6
—
-1,600,000 -43.4%
P
S
2,086,622 $21,262,678 2025 Q4 13F Filing 2026-09-30 2026-11-16
CTNM
CONTINEUM THERA...
Healthcare 0.63% — #23
Prev: #—
3.8
—
704,013 —
NEW
704,013 $9,447,854 2026 Q3 13F Filing 2026-09-30 2026-11-16
ALMS
ALUMIS INC
Healthcare 0.62% 1.80% #24 6
Prev: #18
2.2
—
150,000 13.6%
P
S
1,250,000 $9,237,500 2026 Q2 13F Filing 2026-09-30 2026-11-16
BBOT
BRIDGEBIO ONCOL...
Healthcare 0.62% 1.00% #25 3
Prev: #22
1.2
—
no change no change
P
S
2,250,000 $9,225,000 2025 Q3 13F Filing 2026-09-30 2026-11-16
MQ
MARQETA INC
Technology 0.13% 0.42% #26 2
Prev: #24
0.1
—
-331,169 -75.0%
P
S
110,389 $1,876,061 2021 Q4 13F Filing 2026-09-30 2026-11-16
LNZA
LANZATECH GLOBA...
Industrials 0.06% 0.06% #27 2
Prev: #25
1.0
—
no change no change
P
S
158,148 $903,025 2023 Q1 13F Filing 2026-09-30 2026-11-16
CRNX
CRINETICS PHARM...
Healthcare 0.00% 2.87%
Sold All 😨
(Was: #11)
0.0
—
-1,320,000 -100.0%
CLOSED
— $— 2018 Q3 13F Filing 2026-09-30 2026-11-16
Showing 1-28 of 28 holdings

Unlock Full Novo Holdings A/S Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →